Endiandric Acid Analogues from Beilschmiedia ferruginea as Dual Inhibitors of Bcl-xL/Bak and Mcl-1/Bid Interactions-Reference-Cited by-同舟云学术

Endiandric Acid Analogues from Beilschmiedia ferruginea as Dual Inhibitors of Bcl-xL/Bak and Mcl-1/Bid Interactions

Published:2014-06-05 Issue:6 Volume:77 Page:1430-1437
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Apel Cécile¹,Gény Charlotte¹,Dumontet Vincent¹,Birlirakis Nicolas¹,Roussi Fanny¹,Pham Van Cuong²,Doan Thi Mai Huong²,Nguyen Van Hung²,Chau Van Minh²,Litaudon Marc¹

Affiliation:

1. Centre de Recherche de Gif, Institut de Chimie des Substances Naturelles (ICSN), CNRS, 1 av de la Terrasse, 91198 Gif-sur-Yvette Cedex, France

2. Institute of Marine Biochemistry of the Vietnam Academy of Sciences and Technology (VAST), 18 Hoang Quoc Viet Road, 90184 Cau Giay, Hanoi, Vietnam

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/np500170v

Reference24 articles.

1. Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer

2. BCL-2 family antagonists for cancer therapy

3. Pulling the plug on BCL-XL

4. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy

5. Kingianic Acids A–G, Endiandric Acid Analogues from Endiandra kingiana

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer;European Journal of Pharmacology;2023-04

2. Phytochemistry and antibacterial potential of the genus Beilschmiedia;Advances in Botanical Research;2023

3. Natural Products as Mcl-1 Inhibitors: A Comparative Study of Experimental and Computational Modelling Data;Chemistry;2022-09-06

4. Strategies to Reduce the On‐Target Platelet Toxicity of Bcl‐x _L Inhibitors: PROTACs, SNIPERs and Prodrug‐Based Approaches;ChemBioChem;2022-03-19

5. Drimane Derivatives as the First Examples of Covalent BH3 Mimetics that Target MCL‐1;ChemMedChem;2021-03-23